Using lower limb exoskeletons provides potential advantages in terms of productivity and safety associated with reduced stress. However, complex issues in human-robot interactions are still open, such as the physiological effects of exoskeletons and the impact on the user's subjective experience. In this work, an innovative exoskeleton, the , is assessed using the EXPERIENCE benchmarking protocol from the EUROBENCH project.
View Article and Find Full Text PDFBackground: The use of large language models (LLMs) as writing assistance for medical professionals is a promising approach to reduce the time required for documentation, but there may be practical, ethical, and legal challenges in many jurisdictions complicating the use of the most powerful commercial LLM solutions.
Objective: In this study, we assessed the feasibility of using nonproprietary LLMs of the GPT variety as writing assistance for medical professionals in an on-premise setting with restricted compute resources, generating German medical text.
Methods: We trained four 7-billion-parameter models with 3 different architectures for our task and evaluated their performance using a powerful commercial LLM, namely Anthropic's Claude-v2, as a rater.
Several autism knowledge assessments include "don't know" as a response option. The inclusion of this response option may lead to systematic error, such that participants' guessing rate affects the measurement of their autism knowledge. This study examines both predictors of guessing rate for autism knowledge and predictors of autism knowledge, including guessing rate.
View Article and Find Full Text PDFBackground: Chronic obstructive pulmonary disease (COPD) is an inflammatory multisystemic disease caused by environmental exposures and/or genetic factors. Inherited alpha-1-antitrypsin deficiency (AATD) is one of the best recognized genetic factors increasing the risk for an early onset COPD with emphysema. The aim of this study was to gain a better understanding of the associations between comorbidities and specific biomarkers in COPD patients with and without AATD to enable future investigations aimed, for example, at identifying risk factors or improving care.
View Article and Find Full Text PDF